Lewy Bodies in PD. Lewy Body Inclusions and the effect of coffee and decaffeinated extracts on Drosophila neuronal cultures.

Slides:



Advertisements
Similar presentations
Sporadic AD familial AD etiology environmental factors, genetic predisposition etiology oligomerization of A 42 and initial (diffuse) A 42 deposits subtle.
Advertisements

Synucleinopathies and Tauopathies
Parkinson’s disease: February 19th BIOS E108 Parkin and PINK1
Of neurotoxicity and α-synuclein Richard Wilson Clayton DF & George JM (1999) J Neurosci Res 58, 120–129.
Gene Expression Viruses Biotechnology
Α-Synuclein Interaction with Phospholipids: Possible Implications for Parkinson’s Disease Literature Seminar by Jessica L. Anderson.
Rapid detection of drugs for protein misfolding diseases. Alexey Krasnoslobodtsev, Department of Pharmaceutical Sciences, University of Nebraska Medical.
September 13th BIOS E108 Parkinson’s disease (PD) -Pathology -Diagnosis -  -synuclein.
PHL 437/Pharmacogenomics Fourth Lecture (Parkinson’s disease) By Abdelkader Ashour, Ph.D. Phone:
Parkinson’s Disease Pathology 430/826 The Molecular Basis of Disease Neurological Genetics 9 th March 2015 Dr. John Rossiter
Colon cancer is the second leading cause of cancer deaths in the U.S. Polyps, the first stage In tumor development
Lecture 1: Introduction Dr. Mamoun Ahram Faculty of Medicine Second year, Second semester, Principles of Genetics and Molecular Biology.
Protein-Misfolding Diseases PHY6940 April 8 th 2009 Jessica Nasica.
Module 7.3 Movement Disorders. Parkinson’s Disease A neurological disorder characterized by muscle tremors, rigidity, slow movements and difficulty initiating.
Parkinson’s Disease and Treatment Shalla Hanson Medicinal Chemistry April 2009.
Gene Therapy in Huntington’s Disease Project was done by Rejan Chin & Sharisa Ford.
931-4 Convergence Insufficiency. History A 73-year old man with known PD for 10 years, complained of horizontal double vision for 18 months. He could.
A view into Neurodegeneration and neurodegenerative diseases Bahareh Eftekharzadeh Laboratory of Dr. Xavier Salvatella SemesterI Crazy about Biomedicine.
Chapter 21. Molecular Mechanisms of Neurological Disease Copyright © 2014 Elsevier Inc. All rights reserved.
February 12th BIOS E108 Parkinson’s disease (PD) -Pathology -Diagnosis -  -synuclein.
Biological Myths of Aging Memory declines drastically with age for all people. IQ declines drastically with age in all people. Learning becomes more difficult.
Α-synuclein, Lewy Bodies, Prions, and Parkinson’s Disease Cody McCullough & Sara Homsi BCM 465 April 19 th, 2010.
Parkinson’s Disease superKAT :).
WHAT DO YOU REMEMBER ABOUT ALZHEIMER’S DEMENTIA?.
Introduction Alzheimer’s disease (AD) is a neurodegenerative disease associated with brain shrinkage and the loss of neurons, particularly cholinergic.
Rôle des dysfonctions mitochondriales et lysosomales dans la maladie de Parkinson Jean-Christophe (Chris) Rochet UER Neurohistologie-Neuropathologie Department.
 Phospholipid bilayer  “Mosaic” of proteins The fluid-mosaic model.
PATHOLOGIC AGGREGATION OF THE BRAIN PROTEIN  -SYNUCLEIN CAUSES CELL DEATH IN PARKINSON AND ALZHEIMER DISEASE, Wenbo Zhou, PhD and Curt R. Freed, MD Division.
Mounting Evidence that Endocytosis Regulates  -Synuclein Degradation Jaime Pérez Pineda Advanced Cell Biology Fall 2009.
Memory loss Muscle weakness Loss of voluntary movement Dementia Hallucinations Seizures Jerky body movements Tremors Rigidity Confusion Depression Language.
PARKINSON‘S DISEASE Treatment and models.
Mitochondrial function in Cell death in PD. Pathology Loss of SN pigmented dopamine neurons Lewy bodies Lewy neurites-multiple brain regions Lewy bodies.
Bioinformatics: Practical Application of Simulation and Data Mining Protein Aggregation I Prof. Corey O’Hern Department of Mechanical Engineering & Materials.
Under the supervision of miklós jászberényi
Α-synuclein transgenic mouse models of Parkinson’s disease Michelle Maurer December 2015.
Neurobiology of Dementia Majid Barekatain, M.D., Associate Professor of Psychiatry Neuropsychiatrist Isfahan University of Medical Sciences Ordibehesht.
Pathogenesis and pathology of parkinsonism
Figure 3 Purpose: To further characterize cell-to-cell transmission of α- synuclein using an in vitro coculture model Figure 3(A) Hypothesis: If myc-tagged.
Emma Hahs, Brooke Armistead, Sarah Brown, Sok Kean Khoo Department of Cell and Molecular Biology, College of Liberal Arts and Sciences, Grand Valley State.
Author: Morgan Van Driest Mentor: Dr. Amanda Dickinson.
Sapana Shinde, Aaron Ripley, Dr. Sok Kean Khoo MicroRNA expression studies in rotenone- induced cellular model for Parkinson’s disease Department of Cell.
Parkinson’s Disease.
Preston Ge Institute for Cell Engineering
Module 7.3 Movement Disorders
Biochemistry Free For All
Protein conformational disorders
Protein conformational disorders
Advisor: Shubhik K. DebBurman Department of Biology
Nitric Oxide (NO) and How it Regulates Motor Function
CNS Iron in Parkinson’s Disease
III. Parkinson Disease.
Alpha-synuclein in Parkinson's disease
Parkinson’s Common neurodegenerative disorder ~10-20/1000
Understanding the structure of a protein involved in Parkinson’s disease -My research proposal was “Relating the structure of aggregated alpha synuclein.
Parkinson’s Diseased Proteins in Relation to Autophagy
Understanding the structure of a protein involved in Parkinson’s disease -My research proposal was “Relating the structure of aggregated alpha synuclein.
Figure 2 ER stress and proteostasis in neurodegenerative diseases
New Animal Models for Parkinson's Disease
Natalie Galles S. N. Bose Research Exchange Summer 2016
STP2 & GAPDH: Partners in crime towards -Synuclein Toxicity
Parkinson's Disease Neuron
Mechanisms Underlying Inflammation in Neurodegeneration
Steve S.W. Han, Luis A. Williams, Kevin C. Eggan  Neuron 
Rab GTPases and Membrane Trafficking in Neurodegeneration
Protein Misfolded Oligomers: Experimental Approaches, Mechanism of Formation, and Structure-Toxicity Relationships  Francesco Bemporad, Fabrizio Chiti 
Genetic Animal Models of Parkinson's Disease
Anh Pham Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer’s disease.
Volume 7, Issue 6, Pages (June 2014)
Volume 15, Issue 5, Pages (May 2007)
A Proposed Mechanism for Neurodegeneration in Movement Disorders Characterized by Metal Dyshomeostasis and Oxidative Stress  Benjamin Guy Trist, Dominic.
Presentation transcript:

Lewy Bodies in PD. Lewy Body Inclusions and the effect of coffee and decaffeinated extracts on Drosophila neuronal cultures

Introduction to PD Parkinson’s disease is a chronic neurodegenerative disease characterized by a variety of motor and non- motor symptoms with no proven successful therapy. Typical hallmarks of PD are: 1.Loss of Dopaminergic neurons in the Substantia nigra pars compacta region of the brain leading to motor disorders. 2.Presence of LB in the surviving Dopaminergic Neurons.

Two Types of Parkinson’s disease Sporadic PD: Non-inheritable, onset due to chemical insults resulting in mutations in associated genes such as LRRK2 or SNCA genes Familial PD: Mainly associates to Autosomal dominant mutations in genes such as SNCA. A53T: increases propensity of Fibrillar LB formations E46K: increases Propensity of Protofibrils or Oligomeric a- syn to form A30P: accelerates protofibrillar formation.

What is Alpha-synuclein Alpha synuclein is the culprit of LB formation It is: amino acid protein. The α- syn has a 12-amino acid stretch in the hydrophobic core and is concerned with the fibrillar aggregation in DA cells. 2.Natively unfolded protein with a hydrophobic region and an acidic tail as is the same with beta and gamma synuclein. 3.Believed to be extensively localized in the nucleus and found in the synapse thus the name synuclein. But its function is still under study. Mark R. Cookson, The Biochemistry of Parkinson’s disease

What is LB from other science journals Lewy bodies are fibrillar protein aggregations found in surviving dopaminergic neurons in PD. Its main constituents of interest are α-syn and ubiquitin and β amyloid fibrils. LB forms from Oligomeric α-syn which arises from monomeric α- syn. Some papers say the oligomeric form is toxic which disrupts cellular permeability and LB is a cellular rescue response; others, LB aggregations trigger aptosis. Even though LB are associated with fibrils which can be stained with immunogold, However, it has been tested that A-53T mutant form is able to form aggregates by it self

Drasophila Melanogaster Why Drasophila melanogaster : 1.Cheap and easy to maintain 2.High reproduction rate 3.Entire genome has been sequenced 4.Readily manipulate gene expression in the embryo creating gain or loss-of- function conditions almost at will. A53T line is used because the mutation accelerates LB aggregation

Antibodies and dyes Experiments have been done to show that the 1:5000 of primary antibodies give the best distinction between LB and background signals DAPI: stains the nucleus (Blue) (1:2000) Anti-HRP: stains the Na+K+ channels on cells membrane (Green) ( 1:100 ) Primary antibodies: selectively stain for a-syn (1:5000) Secondary antibodies: selectively binds to primary antibodies and emits orange light. (1:2000)

Objectives: Define Lewy Bodies Quantify the number of LB in A53T cell line over and 9 day-in-vitro (DIV) and total number of DA cells in the same culture. Determine if LB is a cause or a rescue response of PD.

Methodology: Eggling of A53T fruit flies for 4½ to 5 hours. Cells are extracted from the eggs at the right stage. Cells are grown in special mediums for differentiation in to neuronal cells for specific time internal. Caffeine, decaffeinated, Tobacco and Quest drugs are added at 3DIV. Immunocytochemistry Analysis: take images of all LB like aggregations and DA cells. The size of average LB size for each batch is obtained The ratio of DA cells/LB is obtained for each treatment group.

Results for control at 1,2,3,6 and 9DIV Most significant figure in this chart is the average size of LB over time remains stable starting from 2DIV. N=34 N=61N=21 N=18

Provided that the sizes of LB over time is relatively stable from 2 to 9DIV, the ratio of total number of LB cells versus #DA is also stable. However, the ratio for 1DIV is 3 times higher. This information tells me that the formation of LB is between 1DIV and 2DIV.

Coffee and Decaff extract added at 3DIV The addition of coffee and decaff extracts at 3DIV reduces the number of LB in both cases. However, the ratio declines either because of an increase of LB as the drugs are used up over time or a decrease in total number of DA cells. N=769/24 N=823/102 N=615/72 N=276/50

Conclusion: Lewy Body is filamentous protein aggregation with a size range of 4 to 7μm which mainly constitutes α-synuclein and it is up regulated early in drosophila neuronal cultures. From these experiments, the formation of LB is studied in both the absence and presence of neuroprotective drugs. The number of LB increases drastically between 1DIV and 2DIV and stays stable both in numbers and sizes. The data shows that both coffee and decaff extracts reduce the number of LB after LBs are fully formed which implies that these drugs are involved in the degradation of LBs.

References: Auluck et al 2010 Mel B. Feany and Welcome W. Bender. A drosophila model of Parkinson’s disease Pavan K. Auluck, Gabriela Caraveo and Susan Lindquist. Α-synuclein: Membran Interactions and Toxicity In Parkinson’s Disease. Walter J. Schulz-Schaeffer. The synaptic Pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia.